Ranasinghe, Ranmali
< Back to all AuthorsArticle
Article
Ranasinghe, Ranmali ORCID: 0000-0003-3634-2689, Mathai, Michael
ORCID: 0000-0001-8783-2122, Abdullah Alshawsh, Mohammed and Zulli, Anthony
ORCID: 0000-0002-2660-078X
(2024)
Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm.
Heliyon, 10 (7).
ISSN 2405-8440
Ranasinghe, Ranmali ORCID: 0000-0003-3634-2689, Mathai, Michael
ORCID: 0000-0001-8783-2122 and Zulli, Anthony
ORCID: 0000-0002-2660-078X
(2023)
Cytoprotective remedies for ameliorating nephrotoxicity induced by renal oxidative stress.
Life Sciences, 318.
ISSN 0024-3205
Ranasinghe, Ranmali ORCID: 0000-0003-3634-2689, Mathai, Michael
ORCID: 0000-0001-8783-2122 and Zulli, Anthony
ORCID: 0000-0002-2660-078X
(2022)
Cisplatin for cancer therapy and overcoming chemoresistance.
Heliyon, 8 (9).
ISSN 2405-8440
Ranasinghe, Ranmali ORCID: 0000-0003-3634-2689, Mathai, Michael
ORCID: 0000-0001-8783-2122 and Zulli, Anthony
ORCID: 0000-0002-2660-078X
(2022)
Revisiting the therapeutic potential of tocotrienol.
BioFactors.
ISSN 0951-6433
Ranasinghe, Ranmali ORCID: 0000-0003-3634-2689, Mathai, Michael
ORCID: 0000-0001-8783-2122 and Zulli, Anthony
ORCID: 0000-0002-2660-078X
(2022)
A synopsis of modern - day colorectal cancer: where we stand.
Biochimica et Biophysica Acta - Reviews on Cancer, 1877 (2).
ISSN 0304-419X